Phase 2 N=10 Treatment

Tailored Computerized Mobilization of the Cervical Spine Utilizing the Occiflex Device for the Treatment of Chronic Neck Pain

Neck Pain

Bottom Line

View on ClinicalTrials.gov: NCT01518530 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2013

Primary outcome: Primary: Occiflex Device Safety — 26 Number of adverse effects

Study Design & Population

Study type: Interventional
Phase: Phase 2
Interventions: Occiflex Robotic Intervention System (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Hillel Yaffe Medical Center
Primary completion: May 2012

Outcome Measures

Outcome	Result	p-value
PRIMARY Occiflex Device Safety	26	—
SECONDARY Efficacy as Per the NDI-Neck Disability Index	—	—

Summary

The study is intended to examine the safety and efficacy of computerized mobilization of the neck for the treatment of patients with chronic neck pain. This is a third continuation study aimed at examining the Occiflex Robotic System. This time we will be studying tailored or personalized three dimensional movement of the neck.

Eligibility Criteria

Inclusion Criteria

Patients with chronic neck pain: post-whiplash injury, myofacial pain, cervical facet joint disease and idiopathic chronic neck pain

Exclusion Criteria

Patients with cervical radiculopathy Myelopathy Discopathy Malignancy involving the neck or cervical spine Severe Osteoporosis Severe skin disorder Psychiatric disorders Cervical disc herniation

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01518530). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.